[1]
2026. Reassessing Chelerythrine as a Candidate Therapy for Nasopharyngeal Carcinoma. Journal of Environment and Biological Science. 2, 1 (Nov. 2026), 1–3. DOI:https://doi.org/10.64142/jebs.2.1.18.